CA
NZ
UK
AU
IND
US
Revvity (NYSE:RVTY) shares closed near 52-week highs today, fueled by the launch of its GSP T1D 3plex kit, a CE-IVDR-certified diagnostic tool enabling population-wide screening for type 1 diabetes risk in children. The launch extends the company's existing newborn-screening platform into early childhood care, …
Recursion Pharmaceuticals (NASDAQ:RXRX), aPenny Stocktrading under $5 per share, closed higher today, extending a multi-week rally sparked by its expanded partnership with Tempus AI, announced last week. The extended long-term licensing agreement, which runs through 2029, converts up to $84 million in discretionary payments …
Oscar Health (NYSE:OSCR) shares fell further today, extending a multi-day slide tied to renewed policy risk in the ACA marketplace. CMS moved to cancel Affordable Care Act coverage for roughly 760,000 individuals and claw back an estimated $2.2 billion in advance premium subsidies following …
Kailera Therapeutics (NASDAQ:KLRA) shares closed sharply lower today, extending a multi-day decline and hitting fresh 52-week lows, as broader biotech weakness compounds company-specific concerns about weak clinical progress signals versus GLP-1 rivals. The stock has now fallen well below its April 2026 IPO price …
Kodiak Sciences (NASDAQ:KOD) shares closed higher today ahead of pivotal Phase III wet age-related macular degeneration data expected by month-end from the company's DAYBREAK trial. A research firm reiterated a Buy rating with an $80 price target, arguing the recent pullback in shares creates …
GRAIL (NASDAQ:GRAL) shares closed sharply higher today as investors continued responding favorably to Wednesday's FDA advisory panel outcome on its Galleri multi-cancer early detection blood test. The panel unanimously backed Galleri's safety, split 6 to 4 in favor of its clinical effectiveness, and voted …
Iovance Biotherapeutics (NASDAQ:IOVA) shares closed higher today, extending a multi-week surge driven by growing analyst optimism around its Amtagvi (lifileucel) franchise. The move follows recent price target hikes and bullish commentary from analysts citing a clear line of sight to profitability, alongside anticipation of …
CG Oncology (NASDAQ:CGON) shares declined today after Rule 144 filings revealed continued insider stock sales, including a company officer's planned sale tied to a stock option exercise. The insider activity adds to recent selling that has drawn investor scrutiny, even as the company's underlying …
CareDx (NASDAQ:CDNA) shares surged today after the Centers for Medicare and Medicaid Services finalized 2027 clinical lab fee schedule changes that align rates with private payors, a shift analysts view as favorable for CareDx's transplant diagnostics reimbursement outlook. The reaction stands in contrast to …
Bruker (NASDAQ:BRKR) shares closed sharply higher today, outperforming both the broader healthcare sector and the wider market, which have been under pressure from a spike in Treasury yields to post-financial-crisis highs. The move comes as investors responded positively to a steady drumbeat of new …
Please wait processing your request...